Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on ZLAB Stock Analysis and Forecast - Superior returns - Jammu Links News

ZLAB Stock Analysis and Forecast - Superior returns  Jammu Links News

ZLAB Stock Analysis and Forecast - Superior returns - Jammu Links News

Click here to get full coverage on Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywall.st

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33%  simplywall.st

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywall.st

Click here to get full coverage on Insider Sale: Chairperson & CEO of $ZLAB Sells 7,072 Shares - Nasdaq

Insider Sale: Chairperson & CEO of $ZLAB Sells 7,072 Shares  Nasdaq

Insider Sale: Chairperson & CEO of $ZLAB Sells 7,072 Shares - Nasdaq

Click here to get full coverage on Zai Lab Limited: Banking On Chinese Pharma Growth (NASDAQ:ZLAB) - Seeking Alpha

Zai Lab Limited: Banking On Chinese Pharma Growth (NASDAQ:ZLAB)  Seeking Alpha

Zai Lab Limited: Banking On Chinese Pharma Growth (NASDAQ:ZLAB) - Seeking Alpha

Click here to get full coverage on (ZLAB) On The My Stocks Page - news.stocktradersdaily.com

(ZLAB) On The My Stocks Page  news.stocktradersdaily.com

(ZLAB) On The My Stocks Page - news.stocktradersdaily.com

Click here to get full coverage on ZLab ZJoins Mini Review: The Missing Link - Vaping360

ZLab ZJoins Mini Review: The Missing Link  Vaping360

ZLab ZJoins Mini Review: The Missing Link - Vaping360

Click here to get full coverage on ZLAB Stock Analysis and Forecast - Fastest-growing stock picks - Jammu Links News

ZLAB Stock Analysis and Forecast - Fastest-growing stock picks  Jammu Links News

ZLAB Stock Analysis and Forecast - Fastest-growing stock picks - Jammu Links News

Click here to get full coverage on With 73% ownership in Zai Lab Limited (NASDAQ:ZLAB), institutional investors have a lot riding on the business - Yahoo Finance

With 73% ownership in Zai Lab Limited (NASDAQ:ZLAB), institutional investors have a lot riding on the business  Yahoo Finance

With 73% ownership in Zai Lab Limited (NASDAQ:ZLAB), institutional investors have a lot riding on the business - Yahoo Finance

Click here to get full coverage on Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025 - Business Wire

Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025  Business Wire

Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025 - Business Wire

Click here to get full coverage on Zai Lab (ZLAB) Reports Promising Preclinical Data for ZL-1503 in Atopic Dermatitis | ZLAB Stock News - GuruFocus

Zai Lab (ZLAB) Reports Promising Preclinical Data for ZL-1503 in Atopic Dermatitis | ZLAB Stock News  GuruFocus

Zai Lab (ZLAB) Reports Promising Preclinical Data for ZL-1503 in Atopic Dermatitis | ZLAB Stock News - GuruFocus

Click here to get full coverage on Zai Lab to Announce Q2 2025 Financial Results on August 7, 2025 - AInvest

Zai Lab to Announce Q2 2025 Financial Results on August 7, 2025  AInvest

Zai Lab to Announce Q2 2025 Financial Results on August 7, 2025 - AInvest

Click here to get full coverage on Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? - Insider Monkey

Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025?  Insider Monkey

Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? - Insider Monkey

Click here to get full coverage on First NTRK Cancer Treatment in China: NMPA Fast-Tracks Repotrectinib Review for Untreated Patient Market - Stock Titan

First NTRK Cancer Treatment in China: NMPA Fast-Tracks Repotrectinib Review for Untreated Patient Market  Stock Titan

First NTRK Cancer Treatment in China: NMPA Fast-Tracks Repotrectinib Review for Untreated Patient Market - Stock Titan

Click here to get full coverage on Zai Lab Limited Is Well Positioned For Long-Term Growth - Seeking Alpha

Zai Lab Limited Is Well Positioned For Long-Term Growth  Seeking Alpha

Zai Lab Limited Is Well Positioned For Long-Term Growth - Seeking Alpha

Click here to get full coverage on When (ZLAB) Moves Investors should Listen - news.stocktradersdaily.com

When (ZLAB) Moves Investors should Listen  news.stocktradersdaily.com

When (ZLAB) Moves Investors should Listen - news.stocktradersdaily.com

Click here to get full coverage on Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates - Yahoo Finance

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates  Yahoo Finance

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates - Yahoo Finance

Click here to get full coverage on What analysts say about ZLAB stock - Free Stock Market Beginners Guide - Jammu Links News

What analysts say about ZLAB stock - Free Stock Market Beginners Guide  Jammu Links News

What analysts say about ZLAB stock - Free Stock Market Beginners Guide - Jammu Links News

Click here to get full coverage on Zai Lab gets China's acceptance for label expansion of repotrectinib (ZLAB:NASDAQ) - Seeking Alpha

Zai Lab gets China's acceptance for label expansion of repotrectinib (ZLAB:NASDAQ)  Seeking Alpha

Zai Lab gets China's acceptance for label expansion of repotrectinib (ZLAB:NASDAQ) - Seeking Alpha

Click here to get full coverage on Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - Nasdaq

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say  Nasdaq

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - Nasdaq

Click here to get full coverage on Wall Street Analysts Think Zai Lab Limited (ZLAB) Could Surge 64.42%: Read This Before Placing a Bet - Yahoo Finance

Wall Street Analysts Think Zai Lab Limited (ZLAB) Could Surge 64.42%: Read This Before Placing a Bet  Yahoo Finance

Wall Street Analysts Think Zai Lab Limited (ZLAB) Could Surge 64.42%: Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on Zai Lab Lines Up Triple Conference Presence: Jefferies, Goldman Sachs, and Scotiabank Healthcare Events - Stock Titan

Zai Lab Lines Up Triple Conference Presence: Jefferies, Goldman Sachs, and Scotiabank Healthcare Events  Stock Titan

Zai Lab Lines Up Triple Conference Presence: Jefferies, Goldman Sachs, and Scotiabank Healthcare Events - Stock Titan

Click here to get full coverage on 10 Biotech Stocks Screaming a Buy - Insider Monkey

10 Biotech Stocks Screaming a Buy  Insider Monkey

10 Biotech Stocks Screaming a Buy - Insider Monkey

Click here to get full coverage on Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial - Insider Monkey

Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial  Insider Monkey

Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial - Insider Monkey

Click here to get full coverage on Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), LifeMD (LFMD) and Novo Nordisk (NVO) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), LifeMD (LFMD) and Novo Nordisk (NVO)  The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), LifeMD (LFMD) and Novo Nordisk (NVO) - The Globe and Mail

Click here to get full coverage on Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB) - Seeking Alpha

Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB)  Seeking Alpha

Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB) - Seeking Alpha

Click here to get full coverage on Zai Lab says Pfizer drug Tivdak won China review (ZLAB:NASDAQ) - Seeking Alpha

Zai Lab says Pfizer drug Tivdak won China review (ZLAB:NASDAQ)  Seeking Alpha

Zai Lab says Pfizer drug Tivdak won China review (ZLAB:NASDAQ) - Seeking Alpha

Click here to get full coverage on Phase 1 Trial Shows 79% Response Rate for Zai Lab Lung Cancer Drug ZL-1310 | ZLAB Stock News - Stock Titan

Phase 1 Trial Shows 79% Response Rate for Zai Lab Lung Cancer Drug ZL-1310 | ZLAB Stock News  Stock Titan

Phase 1 Trial Shows 79% Response Rate for Zai Lab Lung Cancer Drug ZL-1310 | ZLAB Stock News - Stock Titan

Click here to get full coverage on Compared to Estimates, Zai Lab Limited (ZLAB) Q3 Earnings: A Look at Key Metrics - Nasdaq

Compared to Estimates, Zai Lab Limited (ZLAB) Q3 Earnings: A Look at Key Metrics  Nasdaq

Compared to Estimates, Zai Lab Limited (ZLAB) Q3 Earnings: A Look at Key Metrics - Nasdaq

Click here to get full coverage on Biotech Stock In A Base As Sales Grow 66% And Losses Improve - Investor's Business Daily

Biotech Stock In A Base As Sales Grow 66% And Losses Improve  Investor's Business Daily

Biotech Stock In A Base As Sales Grow 66% And Losses Improve - Investor's Business Daily

Click here to get full coverage on Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks - Seeking Alpha

Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks  Seeking Alpha

Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks - Seeking Alpha

Click here to get full coverage on Exploring the ZLab Z-Ecosystem: Versatility Reimagined! - Vaping360

Exploring the ZLab Z-Ecosystem: Versatility Reimagined!  Vaping360

Exploring the ZLab Z-Ecosystem: Versatility Reimagined! - Vaping360

Click here to get full coverage on Press Release: Join Us at Intertabac 2024 for ZLab’s Highly Anticipated Launch! - Vaping360

Press Release: Join Us at Intertabac 2024 for ZLab’s Highly Anticipated Launch!  Vaping360

Press Release: Join Us at Intertabac 2024 for ZLab’s Highly Anticipated Launch! - Vaping360

Click here to get full coverage on Zai Lab Announces Pricing of Public Offering of American Depositary Shares - Business Wire

Zai Lab Announces Pricing of Public Offering of American Depositary Shares  Business Wire

Zai Lab Announces Pricing of Public Offering of American Depositary Shares - Business Wire

Click here to get full coverage on Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates - Business Wire

Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates  Business Wire

Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates - Business Wire

Click here to get full coverage on Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025 - Business Wire

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025  Business Wire

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025 - Business Wire

Click here to get full coverage on Breakthrough: Zai Lab's Dual Cancer Therapies Show Promise in Resistant Tumors at AACR 2025 - Stock Titan

Breakthrough: Zai Lab's Dual Cancer Therapies Show Promise in Resistant Tumors at AACR 2025  Stock Titan

Breakthrough: Zai Lab's Dual Cancer Therapies Show Promise in Resistant Tumors at AACR 2025 - Stock Titan

Click here to get full coverage on Zai Lab Announces Proposed Public Offering of American Depositary Shares - Business Wire

Zai Lab Announces Proposed Public Offering of American Depositary Shares  Business Wire

Zai Lab Announces Proposed Public Offering of American Depositary Shares - Business Wire

Click here to get full coverage on Zai lab CEO Du Ying sells $3.35m in shares - Investing.com

Zai lab CEO Du Ying sells $3.35m in shares  Investing.com

Zai lab CEO Du Ying sells $3.35m in shares - Investing.com

Click here to get full coverage on ZLand & ZColors Review: Might Be the Best Ever! - Vaping360

ZLand & ZColors Review: Might Be the Best Ever!  Vaping360

ZLand & ZColors Review: Might Be the Best Ever! - Vaping360

Click here to get full coverage on ZLAB stock hits 52-week high at $39.81 amid robust growth - Investing.com Nigeria

ZLAB stock hits 52-week high at $39.81 amid robust growth  Investing.com Nigeria

ZLAB stock hits 52-week high at $39.81 amid robust growth - Investing.com Nigeria

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting | ZLAB Stock News - GuruFocus

Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting | ZLAB Stock News  GuruFocus

Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting | ZLAB Stock News - GuruFocus

Click here to get full coverage on Cantor Fitzgerald maintains Overweight on ZLAB amid tariffs By Investing.com - Investing.com South Africa

Cantor Fitzgerald maintains Overweight on ZLAB amid tariffs By Investing.com  Investing.com South Africa

Cantor Fitzgerald maintains Overweight on ZLAB amid tariffs By Investing.com - Investing.com South Africa

Click here to get full coverage on Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025 - Business Wire

Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025  Business Wire

Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025 - Business Wire

Click here to get full coverage on Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate - Business Wire

Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate  Business Wire

Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate - Business Wire

Click here to get full coverage on Zai Lab CEO Du Ying sells $208k in shares - Investing.com

Zai Lab CEO Du Ying sells $208k in shares  Investing.com

Zai Lab CEO Du Ying sells $208k in shares - Investing.com

Click here to get full coverage on Zai Lab Announces Participation in Investor Conferences in March 2025 - Yahoo Finance

Zai Lab Announces Participation in Investor Conferences in March 2025  Yahoo Finance

Zai Lab Announces Participation in Investor Conferences in March 2025 - Yahoo Finance

Click here to get full coverage on Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025 - Yahoo Finance

Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025  Yahoo Finance

Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025 - Yahoo Finance

Click here to get full coverage on Tanner Zlab - Football 2016 - University of Nebraska - Official Athletics Website - huskers.com

Tanner Zlab - Football 2016 - University of Nebraska - Official Athletics Website  huskers.com

Tanner Zlab - Football 2016 - University of Nebraska - Official Athletics Website - huskers.com

Click here to get full coverage on Press Release: ZLab Breaks Through with the Next Generation of Vapes - Vaping360

Press Release: ZLab Breaks Through with the Next Generation of Vapes  Vaping360

Press Release: ZLab Breaks Through with the Next Generation of Vapes - Vaping360

Click here to get full coverage on This Biotech Leader Just Hit A 16-Month High On An 'Impressive' Test - Investor's Business Daily

This Biotech Leader Just Hit A 16-Month High On An 'Impressive' Test  Investor's Business Daily

This Biotech Leader Just Hit A 16-Month High On An 'Impressive' Test - Investor's Business Daily

Click here to get full coverage on Trade of the Day: Zai Lab (ZLAB) Stock Is a Possible Hidden Gem - Nasdaq

Trade of the Day: Zai Lab (ZLAB) Stock Is a Possible Hidden Gem  Nasdaq

Trade of the Day: Zai Lab (ZLAB) Stock Is a Possible Hidden Gem - Nasdaq

Click here to get full coverage on JPMorgan Adjusts Price Target on Zai Lab to $51 From $44, Keeps Overweight Rating - MarketScreener

JPMorgan Adjusts Price Target on Zai Lab to $51 From $44, Keeps Overweight Rating  MarketScreener

JPMorgan Adjusts Price Target on Zai Lab to $51 From $44, Keeps Overweight Rating - MarketScreener

Click here to get full coverage on ZLab Introduces Z-Land Series with Modular Design at ANTY EXPO - 2Firsts

ZLab Introduces Z-Land Series with Modular Design at ANTY EXPO  2Firsts

ZLab Introduces Z-Land Series with Modular Design at ANTY EXPO - 2Firsts

Click here to get full coverage on Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore - Business Wire

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore  Business Wire

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore - Business Wire

Zai Lab Ltd (ZLAB)

Price Chart

Key Statistics

Technicals

About ZLAB

Latest News

ZLAB Stock Analysis and Forecast - Superior returns - Jammu Links News

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywall.st

Insider Sale: Chairperson & CEO of $ZLAB Sells 7,072 Shares - Nasdaq

Advanced Charts

Top Gainers

Top Losers